Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?
Department of Hepatology and Gastroenterology, Liver Unit, Niguarda Hospital, Milan, Italy. Electronic address: claudio.zavaglia@ospedaleniguarda.it.
Claudio
C
Zavaglia
Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy; International Center for Digestive Health, University of Milan-Bicocca, Milan, Italy.
Stefano
S
Okolicsanyi
Department of Hepatology and Gastroenterology, Liver Unit, Niguarda Hospital, Milan, Italy.
Lucia
L
Cesarini
Department of Hepatology and Gastroenterology, Liver Unit, Niguarda Hospital, Milan, Italy.
Chiara
C
Mazzarelli
Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy; International Center for Digestive Health, University of Milan-Bicocca, Milan, Italy.
Valerio
V
Pontecorvi
Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy; International Center for Digestive Health, University of Milan-Bicocca, Milan, Italy.
Antonio
A
Ciaccio
Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy; International Center for Digestive Health, University of Milan-Bicocca, Milan, Italy.
Mario
M
Strazzabosco
Department of Hepatology and Gastroenterology, Liver Unit, Niguarda Hospital, Milan, Italy; International Center for Digestive Health, University of Milan-Bicocca, Milan, Italy.
Luca Saverio
LS
Belli
D000998:Antiviral Agents; D006528:Carcinoma, Hepatocellular; D006526:Hepatitis C; D006801:Humans; D008113:Liver Neoplasms; D009364:Neoplasm Recurrence, Local
D000998:Antiviral Agents